Share on StockTwits

Humana (NYSE:HUM) has earned an average recommendation of “Hold” from the twenty-three analysts that are covering the company, Stock Ratings reports. Two investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and four have given a buy rating to the company. The average 12-month price target among brokerages that have covered the stock in the last year is $126.00.

Shares of Humana (NYSE:HUM) opened at 118.11 on Tuesday. Humana has a 1-year low of $90.19 and a 1-year high of $134.93. The stock’s 50-day moving average is $126.8 and its 200-day moving average is $115.5. The company has a market cap of $18.219 billion and a price-to-earnings ratio of 17.41.

Humana (NYSE:HUM) last released its earnings data on Wednesday, July 30th. The company reported $2.19 earnings per share (EPS) for the quarter, meeting the consensus estimate of $2.19. During the same quarter in the previous year, the company posted $2.63 earnings per share. Analysts expect that Humana will post $7.79 EPS for the current fiscal year.

A number of analysts have recently weighed in on HUM shares. Analysts at Raymond James reiterated an “outperform” rating on shares of Humana in a research note on Thursday. They now have a $128.00 price target on the stock, up previously from $123.00. Separately, analysts at Leerink Swann raised their price target on shares of Humana to $140.00 in a research note on Friday, August 1st. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Humana in a research note on Thursday, July 31st. They now have a $126.00 price target on the stock.

Humana Inc (NYSE:HUM) is a health care company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.